Pleiotropic Effects of p300-mediated Acetylation on p68 and p72 RNA Helicase

被引:53
作者
Mooney, Steven M.
Goel, Apollina
D'Assoro, Antonino B.
Salisbury, Jeffrey L.
Janknecht, Ralf [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA
关键词
TRANSCRIPTION FACTOR ER81; ETS PROTEIN ER81; ESTROGEN-RECEPTOR-ALPHA; CREB-BINDING-PROTEIN; DEAD-BOX PROTEINS; BREAST-CANCER; PROSTATE-CANCER; COLORECTAL-CANCER; ANDROGEN RECEPTOR; CELL-GROWTH;
D O I
10.1074/jbc.M110.143792
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Here, we demonstrate that p68 (DDX5) and p72 (DDX17), two homologous RNA helicases and transcriptional cofactors, are substrates for the acetyltransferase p300 in vitro and in vivo. Mutation of acetylation sites affected the binding of p68/p72 to histone deacetylases, but not to p300 or estrogen receptor. Acetylation additionally increased the stability of p68 and p72 RNA helicase and stimulated their ability to coactivate the estrogen receptor, thereby potentially contributing to its aberrant activation in breast tumors. Also, acetylation of p72, but not of p68 RNA helicase, enhanced p53-dependent activation of the MDM2 promoter, pointing at another mechanism of how p72 acetylation may facilitate carcinogenesis by boosting the negative p53-MDM2 feedback loop. Furthermore, blocking p72 acetylation caused cell cycle arrest and apoptosis, revealing an essential role for p72 acetylation. In conclusion, our report has identified for the first time that acetylation modulates RNA helicases and provides multiple mechanisms how acetylation of p68 and p72 may affect normal and tumor cells.
引用
收藏
页码:30443 / 30452
页数:10
相关论文
共 82 条
[1]   The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor [J].
Bates, GJ ;
Nicol, SM ;
Wilson, BJ ;
Jacobs, AMF ;
Bourdon, JC ;
Wardrop, J ;
Gregory, DJ ;
Lane, DP ;
Perkins, ND ;
Fuller-Pace, FV .
EMBO JOURNAL, 2005, 24 (03) :543-553
[2]   A SINGLE AUTOPHOSPHORYLATION SITE CONFERS ONCOGENICITY TO THE NEU/ERBB-2 RECEPTOR AND ENABLES COUPLING TO THE MAP KINASE PATHWAY [J].
BENLEVY, R ;
PATERSON, HF ;
MARSHALL, CJ ;
YARDEN, Y .
EMBO JOURNAL, 1994, 13 (14) :3302-3311
[3]   The long unwinding road of RNA helicases [J].
Bleichert, Franziska ;
Baserga, Susan J. .
MOLECULAR CELL, 2007, 27 (03) :339-352
[4]   Quantitative structure-activity analysis correlating Ras/Raf interaction in vitro to Raf activation in vivo [J].
Block, C ;
Janknecht, R ;
Herrmann, C ;
Nassar, N ;
Wittinghofer, A .
NATURE STRUCTURAL BIOLOGY, 1996, 3 (03) :244-251
[5]  
BOFFA LC, 1978, J BIOL CHEM, V253, P3364
[6]   MDM2 is a central node in the p53 pathway: 12 years and counting [J].
Bond, GL ;
Hu, WW ;
Levine, AJ .
CURRENT CANCER DRUG TARGETS, 2005, 5 (01) :3-8
[7]   PREVALENCE OF RAS GENE-MUTATIONS IN HUMAN COLORECTAL CANCERS [J].
BOS, JL ;
FEARON, ER ;
HAMILTON, SR ;
VERLAANDEVRIES, M ;
VANBOOM, JH ;
VANDEREB, AJ ;
VOGELSTEIN, B .
NATURE, 1987, 327 (6120) :293-297
[8]   Regulation of HER2/Neu promoter activity by the ETS transcription factor, ER81 [J].
Bosc, DG ;
Janknecht, R .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 86 (01) :174-183
[9]   HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1 [J].
Bosc, DG ;
Goueli, BS ;
Janknecht, R .
ONCOGENE, 2001, 20 (43) :6215-6224
[10]   p53 ubiquitination: Mdm2 and beyond [J].
Brooks, CL ;
Gu, W .
MOLECULAR CELL, 2006, 21 (03) :307-315